Sestamibi parathyroid scintigraphy in multigland disease

Nuclear Medicine Communications

Volumn 33, Issue 1, 2012, Pages 43-50

  Nichols, Kenneth J ^a   Tomas, Maria B ^a   Tronco, Gene G ^a   Palestro, Christopher J ^a  

^a Northwell Health   (United States)

Author keywords

hyperparathyroidism; parathyroid diseases; primary; radionuclide imaging; sensitivity and specificity; Technetium Tc 99m Sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE SUBTRACTION; MAJOR CLINICAL STUDY; MALE; PARATHYROID SCINTISCANNING; PRIMARY HYPERPARATHYROIDISM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 82555165800     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834bfeb1     Document Type: Article

References (24)

1. Attie JN,Wise L, Mir R, Ackerman LV. The rationale against routine subtotal parathyroidectomy for primary hyperparathyroidism. Am J Surg 1978; 136:437-444. (Pubitemid 9027649)
2. Shaha AR, Jaffe BM. Cervical exploration for primary hyperparathyroidism. J Surg Oncol 1993; 52:14-17. (Pubitemid 23032101)
3. Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 1998; 186: 293-305.
4. Gough I. Reoperative parathyroid surgery: The importance of ectopic location and multigland disease. ANZ J Surg 2006; 76:1048-1050. (Pubitemid 44949025)
5. Bergson EJ, Sznyter LA, Dubner S, Palestro CJ, Heller KS. Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 2004; 130:87-91. (Pubitemid 38095436)
6. Rubello D, Pelizzo MR, Boni G, Schiavo R, Vaggelli L, Villa G, et al. Radioguided surgery of primary hyperparathyroidism using the low-dose 99mTc-sestamibi protocol: Multiinstitutional experience from the Italian study group on radioguided surgery and immunoscintigraphy (GISCRIS). J Nucl Med 2005; 46:220-226. (Pubitemid 43073427)
7. Pattou F, Huglo D, Proye C. Radionuclide scanning in parathyroid diseases. Br J Surg 1998; 85:1605-1616. (Pubitemid 28548334)
8. Nichols KJ, Tomas MB, Tronco GG, Rini JN, Kunjummen BD, Heller KS, et al. Optimizing the accuracy of preoperative parathyroid lesion localization. Radiology 2008; 248:221-232.
9. Elaraj DM, Sippel RS, Lindsay S, Sansano L, Duh Q-Y, Clark OH, et al. Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 2010; 145:578-581.
10. Berber E, Parikh RT, Ballem N, Garner CN, Milas M, Siperstein AE. Factors contributing to negative parathyroid localization: An analysis of 1000 patients. Surgery 2008; 144:74-79.
11. Chiu B, Sturgeon C, Angelos P. What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy. Surgery 2006; 140:418-422.
12. Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003; 44:1443-1458. (Pubitemid 39663359)
13. Maxon HR, Elgazzar AH. Parathyroid imaging. In: Gelfand MJ, Thomas SR, editors. Effective use of computers in nuclear medicine New York: McGraw-Hill. 1988; pp. 485-496.
14. Milas M, Wagner K, Easley KA, Siperstein A, Weber CJ. Double adenomas revisited: Nonuniform distribution favors enlarged superior parathyroids (fourth pouch disease). Surgery 2003; 134:995-1004. (Pubitemid 38010746)
15. Bhatnagar A, Vezza PR, Bryan JA, Atkins FB, Ziessman HA. Technetium-99m-sestamibi parathyroid scintigraphy: Effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998; 39:1617-1620. (Pubitemid 28459899)
16. Shiau YC, Tsai SC,Wang JJ, Ho ST, Kao A. Detecting parathyroid adenoma using technetium-99m tetrofosmin: Comparison with P-glycoprotein and multidrug resistance related protein expression -a preliminary report. Nucl Med Biol 2002; 29:339-344. (Pubitemid 34258556)
17. Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, et al. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg 2007; 142:381-386. (Pubitemid 46798433)
18. O'Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: Preoperative localization and tissue uptake studies. J Nucl Med 1992; 33:313-318.
19. Derwahl M, Studer H. Hyperplasia versus adenoma in endocrine tissues: Are they different? TRENDS Endocrinol Metab 2002; 13:23-28. (Pubitemid 36734012)
20. Johnson SJ. Changing clinicopathological practice in parathyroid disease. Histopathology 2010; 56:835-851.
21. Jennings T, DeLellis R, Lloyd R, Merino M, LiVolsi V. Recommendations for the reporting of parathyroid specimens. The Association of Directors of Anatomic and Surgical Pathology, 2004. Available at: Www.adasp.org [Accessed 26 August 2011].
22. DeLellis RA. Tumors of the Parathyroid Gland Fascicle 6, Third Series, Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1993.
23. Bondeson AG, Bondeson L, Ljungberg O, Tibblin S. Fat staining in parathyroid disease-diagnostic value and impact on surgical strategy: Clinicopathologic analysis of 191 cases. Hum Pathol 1985; 16:1255-1263. (Pubitemid 16170151)
24. Ghandur-Mnaymneh L, Kimura N. The parathyroid adenoma: A histopathologic definition with a study of 172 cases of primary hyperparathyroidism. Am J Pathol 1984; 115:70-83. (Pubitemid 14171540)